HEADER TRANSFERASE 12-JAN-06 2FO0 TITLE ORGANIZATION OF THE SH3-SH2 UNIT IN ACTIVE AND INACTIVE FORMS OF THE TITLE 2 C-ABL TYROSINE KINASE COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1 (1B ISOFORM); COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: ABL N-CAP (RESIDUES 1-531, RESIDUES 15-56 DELETED); COMPND 5 EC: 2.7.1.112; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: C-ABL; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PFASTBAC1 KEYWDS N-TERMINAL CAP, AUTOINHIBITION, MYRISTOYLATION, SH3-SH2 CLAMP, KEYWDS 2 PHOSPHOSERINE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR B.NAGAR,O.HANTSCHEL,M.SEELIGER,J.M.DAVIES,W.I.WEIS,G.SUPERTI-FURGA, AUTHOR 2 J.KURIYAN REVDAT 9 30-OCT-24 2FO0 1 REMARK REVDAT 8 30-AUG-23 2FO0 1 REMARK REVDAT 7 20-OCT-21 2FO0 1 SEQADV REVDAT 6 30-JUN-21 2FO0 1 REMARK SEQADV LINK ATOM REVDAT 5 02-AUG-17 2FO0 1 SOURCE REVDAT 4 13-JUL-11 2FO0 1 VERSN REVDAT 3 24-FEB-09 2FO0 1 VERSN REVDAT 2 04-APR-06 2FO0 1 AUTHOR REVDAT 1 21-MAR-06 2FO0 0 JRNL AUTH B.NAGAR,O.HANTSCHEL,M.SEELIGER,J.M.DAVIES,W.I.WEIS, JRNL AUTH 2 G.SUPERTI-FURGA,J.KURIYAN JRNL TITL ORGANIZATION OF THE SH3-SH2 UNIT IN ACTIVE AND INACTIVE JRNL TITL 2 FORMS OF THE C-ABL TYROSINE KINASE. JRNL REF MOL.CELL V. 21 787 2006 JRNL REFN ISSN 1097-2765 JRNL PMID 16543148 JRNL DOI 10.1016/J.MOLCEL.2006.01.035 REMARK 2 REMARK 2 RESOLUTION. 2.27 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.27 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.14 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 318702.330 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 90.3 REMARK 3 NUMBER OF REFLECTIONS : 24283 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.210 REMARK 3 FREE R VALUE : 0.246 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 6.800 REMARK 3 FREE R VALUE TEST SET COUNT : 1656 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.006 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.27 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.41 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 73.50 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3000 REMARK 3 BIN R VALUE (WORKING SET) : 0.2700 REMARK 3 BIN FREE R VALUE : 0.2800 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 7.30 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 235 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.018 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3748 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 56 REMARK 3 SOLVENT ATOMS : 145 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 17.20 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 38.80 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -9.32000 REMARK 3 B22 (A**2) : -10.46000 REMARK 3 B33 (A**2) : 19.77000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.27 REMARK 3 ESD FROM SIGMAA (A) : 0.35 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.33 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.33 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.70 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.850 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.580 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.680 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.230 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.400 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.38 REMARK 3 BSOL : 33.70 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : LIGANDS.PAR REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN_REP.TOP REMARK 3 TOPOLOGY FILE 2 : LIGANDS.TOP REMARK 3 TOPOLOGY FILE 3 : WATER_REP.TOP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2FO0 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-FEB-06. REMARK 100 THE DEPOSITION ID IS D_1000036103. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 24-SEP-03 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 8.2.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.1 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL, SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25639 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.270 REMARK 200 RESOLUTION RANGE LOW (A) : 48.140 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.5 REMARK 200 DATA REDUNDANCY : 4.100 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.09500 REMARK 200 FOR THE DATA SET : 14.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.27 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.35 REMARK 200 COMPLETENESS FOR SHELL (%) : 76.5 REMARK 200 DATA REDUNDANCY IN SHELL : 2.50 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.28900 REMARK 200 FOR SHELL : 3.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1OPK REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.78 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.50 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% PEG 10000, 0.1M HEPES, PH 7.5, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 39.84400 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 58.63300 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 39.84400 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 58.63300 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 GLY A 2 REMARK 465 GLN A 3 REMARK 465 GLN A 4 REMARK 465 PRO A 5 REMARK 465 GLY A 6 REMARK 465 LYS A 7 REMARK 465 VAL A 8 REMARK 465 LEU A 9 REMARK 465 GLY A 10 REMARK 465 ASP A 11 REMARK 465 GLN A 12 REMARK 465 ARG A 13 REMARK 465 ARG A 14 REMARK 465 GLU A 57 REMARK 465 PRO A 58 REMARK 465 GLN A 59 REMARK 465 GLY A 60 REMARK 465 LEU A 61 REMARK 465 SER A 62 REMARK 465 GLU A 63 REMARK 465 ALA A 64 REMARK 465 LYS A 531 REMARK 465 GLU A 532 REMARK 465 ASN A 533 REMARK 465 LEU A 534 REMARK 465 TYR A 535 REMARK 465 GLY A 536 REMARK 465 GLN A 537 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 77 C - N - CA ANGL. DEV. = 11.2 DEGREES REMARK 500 PRO A 82 C - N - CA ANGL. DEV. = 11.9 DEGREES REMARK 500 PRO A 82 C - N - CD ANGL. DEV. = -14.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TRP A 67 76.61 -106.09 REMARK 500 SEP A 69 25.96 -78.09 REMARK 500 ASP A 226 60.49 38.86 REMARK 500 ARG A 239 -70.08 -47.15 REMARK 500 ASP A 252 68.89 35.79 REMARK 500 LYS A 253 56.58 -114.03 REMARK 500 LYS A 264 -145.76 -123.32 REMARK 500 ASP A 295 -8.19 -59.68 REMARK 500 MET A 297 77.59 -68.74 REMARK 500 HIS A 380 -60.91 -101.49 REMARK 500 ARG A 381 -3.96 80.44 REMARK 500 ASP A 400 43.06 -95.45 REMARK 500 ASP A 410 160.01 176.92 REMARK 500 TRP A 495 30.57 -96.58 REMARK 500 LEU A 529 -62.35 -91.46 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 MYR A 701 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MYR A 701 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE P16 A 702 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 703 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 704 REMARK 999 REMARK 999 SEQUENCE REMARK 999 RESIDUES 15-56 OF THE ORIGINAL PROTEIN SEQUENCE WERE REMARK 999 DELETED. MYRISTOYL GROUP (MYR) IS COVALENTLY ATTACHED TO THE REMARK 999 N-TERMINUS OF THE PROTEIN. DBREF 2FO0 A 1 14 UNP P00519-2 ABL1_HUMAN 1 14 DBREF 2FO0 A 57 531 UNP P00519-2 ABL1_HUMAN 57 531 SEQADV 2FO0 SEP A 69 UNP P00519-2 SER 69 MODIFIED RESIDUE SEQADV 2FO0 ASN A 382 UNP P00519-2 ASP 382 ENGINEERED MUTATION SEQADV 2FO0 GLU A 532 UNP P00519-2 CLONING ARTIFACT SEQADV 2FO0 ASN A 533 UNP P00519-2 CLONING ARTIFACT SEQADV 2FO0 LEU A 534 UNP P00519-2 CLONING ARTIFACT SEQADV 2FO0 TYR A 535 UNP P00519-2 CLONING ARTIFACT SEQADV 2FO0 GLY A 536 UNP P00519-2 CLONING ARTIFACT SEQADV 2FO0 GLN A 537 UNP P00519-2 CLONING ARTIFACT SEQRES 1 A 495 MET GLY GLN GLN PRO GLY LYS VAL LEU GLY ASP GLN ARG SEQRES 2 A 495 ARG GLU PRO GLN GLY LEU SER GLU ALA ALA ARG TRP ASN SEQRES 3 A 495 SEP LYS GLU ASN LEU LEU ALA GLY PRO SER GLU ASN ASP SEQRES 4 A 495 PRO ASN LEU PHE VAL ALA LEU TYR ASP PHE VAL ALA SER SEQRES 5 A 495 GLY ASP ASN THR LEU SER ILE THR LYS GLY GLU LYS LEU SEQRES 6 A 495 ARG VAL LEU GLY TYR ASN HIS ASN GLY GLU TRP CYS GLU SEQRES 7 A 495 ALA GLN THR LYS ASN GLY GLN GLY TRP VAL PRO SER ASN SEQRES 8 A 495 TYR ILE THR PRO VAL ASN SER LEU GLU LYS HIS SER TRP SEQRES 9 A 495 TYR HIS GLY PRO VAL SER ARG ASN ALA ALA GLU TYR LEU SEQRES 10 A 495 LEU SER SER GLY ILE ASN GLY SER PHE LEU VAL ARG GLU SEQRES 11 A 495 SER GLU SER SER PRO GLY GLN ARG SER ILE SER LEU ARG SEQRES 12 A 495 TYR GLU GLY ARG VAL TYR HIS TYR ARG ILE ASN THR ALA SEQRES 13 A 495 SER ASP GLY LYS LEU TYR VAL SER SER GLU SER ARG PHE SEQRES 14 A 495 ASN THR LEU ALA GLU LEU VAL HIS HIS HIS SER THR VAL SEQRES 15 A 495 ALA ASP GLY LEU ILE THR THR LEU HIS TYR PRO ALA PRO SEQRES 16 A 495 LYS ARG ASN LYS PRO THR VAL TYR GLY VAL SER PRO ASN SEQRES 17 A 495 TYR ASP LYS TRP GLU MET GLU ARG THR ASP ILE THR MET SEQRES 18 A 495 LYS HIS LYS LEU GLY GLY GLY GLN TYR GLY GLU VAL TYR SEQRES 19 A 495 GLU GLY VAL TRP LYS LYS TYR SER LEU THR VAL ALA VAL SEQRES 20 A 495 LYS THR LEU LYS GLU ASP THR MET GLU VAL GLU GLU PHE SEQRES 21 A 495 LEU LYS GLU ALA ALA VAL MET LYS GLU ILE LYS HIS PRO SEQRES 22 A 495 ASN LEU VAL GLN LEU LEU GLY VAL CYS THR ARG GLU PRO SEQRES 23 A 495 PRO PHE TYR ILE ILE THR GLU PHE MET THR TYR GLY ASN SEQRES 24 A 495 LEU LEU ASP TYR LEU ARG GLU CYS ASN ARG GLN GLU VAL SEQRES 25 A 495 ASN ALA VAL VAL LEU LEU TYR MET ALA THR GLN ILE SER SEQRES 26 A 495 SER ALA MET GLU TYR LEU GLU LYS LYS ASN PHE ILE HIS SEQRES 27 A 495 ARG ASN LEU ALA ALA ARG ASN CYS LEU VAL GLY GLU ASN SEQRES 28 A 495 HIS LEU VAL LYS VAL ALA ASP PHE GLY LEU SER ARG LEU SEQRES 29 A 495 MET THR GLY ASP THR TYR THR ALA HIS ALA GLY ALA LYS SEQRES 30 A 495 PHE PRO ILE LYS TRP THR ALA PRO GLU SER LEU ALA TYR SEQRES 31 A 495 ASN LYS PHE SER ILE LYS SER ASP VAL TRP ALA PHE GLY SEQRES 32 A 495 VAL LEU LEU TRP GLU ILE ALA THR TYR GLY MET SER PRO SEQRES 33 A 495 TYR PRO GLY ILE ASP LEU SER GLN VAL TYR GLU LEU LEU SEQRES 34 A 495 GLU LYS ASP TYR ARG MET GLU ARG PRO GLU GLY CYS PRO SEQRES 35 A 495 GLU LYS VAL TYR GLU LEU MET ARG ALA CYS TRP GLN TRP SEQRES 36 A 495 ASN PRO SER ASP ARG PRO SER PHE ALA GLU ILE HIS GLN SEQRES 37 A 495 ALA PHE GLU THR MET PHE GLN GLU SER SER ILE SER ASP SEQRES 38 A 495 GLU VAL GLU LYS GLU LEU GLY LYS GLU ASN LEU TYR GLY SEQRES 39 A 495 GLN MODRES 2FO0 SEP A 69 SER PHOSPHOSERINE HET SEP A 69 10 HET MYR A 701 15 HET P16 A 702 29 HET GOL A 703 6 HET GOL A 704 6 HETNAM SEP PHOSPHOSERINE HETNAM MYR MYRISTIC ACID HETNAM P16 6-(2,6-DICHLOROPHENYL)-2-{[3-(HYDROXYMETHYL) HETNAM 2 P16 PHENYL]AMINO}-8-METHYLPYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE HETNAM GOL GLYCEROL HETSYN SEP PHOSPHONOSERINE HETSYN P16 PD166326 HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 1 SEP C3 H8 N O6 P FORMUL 2 MYR C14 H28 O2 FORMUL 3 P16 C21 H16 CL2 N4 O2 FORMUL 4 GOL 2(C3 H8 O3) FORMUL 6 HOH *145(H2 O) HELIX 1 1 TRP A 67 LEU A 73 5 7 HELIX 2 2 GLY A 76 ASN A 80 5 5 HELIX 3 3 SER A 140 HIS A 144 5 5 HELIX 4 4 SER A 152 LEU A 160 1 9 HELIX 5 5 THR A 213 VAL A 224 1 12 HELIX 6 6 GLU A 257 THR A 259 5 3 HELIX 7 7 GLY A 268 GLN A 271 5 4 HELIX 8 8 LYS A 282 SER A 284 5 3 HELIX 9 9 GLU A 298 ILE A 312 1 15 HELIX 10 10 ASN A 341 CYS A 349 1 9 HELIX 11 11 ASN A 355 LYS A 376 1 22 HELIX 12 12 ALA A 384 ARG A 386 5 3 HELIX 13 13 GLU A 392 HIS A 394 5 3 HELIX 14 14 PRO A 421 THR A 425 5 5 HELIX 15 15 ALA A 426 ASN A 433 1 8 HELIX 16 16 SER A 436 THR A 453 1 18 HELIX 17 17 ASP A 463 LYS A 473 1 11 HELIX 18 18 PRO A 484 TRP A 495 1 12 HELIX 19 19 ASN A 498 ARG A 502 5 5 HELIX 20 20 SER A 504 THR A 514 1 11 HELIX 21 21 SER A 520 GLY A 530 1 11 SHEET 1 A 5 GLY A 126 PRO A 131 0 SHEET 2 A 5 TRP A 118 THR A 123 -1 N ALA A 121 O GLY A 128 SHEET 3 A 5 LYS A 106 TYR A 112 -1 N GLY A 111 O GLU A 120 SHEET 4 A 5 PHE A 85 ALA A 87 -1 N PHE A 85 O LEU A 107 SHEET 5 A 5 ILE A 135 PRO A 137 -1 O THR A 136 N VAL A 86 SHEET 1 B 5 TYR A 147 PRO A 150 0 SHEET 2 B 5 SER A 167 GLU A 172 1 O VAL A 170 N HIS A 148 SHEET 3 B 5 ARG A 180 TYR A 186 -1 O ARG A 185 N SER A 167 SHEET 4 B 5 ARG A 189 THR A 197 -1 O TYR A 191 N LEU A 184 SHEET 5 B 5 LEU A 203 TYR A 204 -1 O TYR A 204 N ASN A 196 SHEET 1 C 3 TYR A 147 PRO A 150 0 SHEET 2 C 3 SER A 167 GLU A 172 1 O VAL A 170 N HIS A 148 SHEET 3 C 3 TYR A 234 PRO A 235 1 O TYR A 234 N PHE A 168 SHEET 1 D 5 ILE A 261 LYS A 266 0 SHEET 2 D 5 VAL A 275 TRP A 280 -1 O GLU A 277 N HIS A 265 SHEET 3 D 5 LEU A 285 THR A 291 -1 O LEU A 285 N TRP A 280 SHEET 4 D 5 TYR A 331 GLU A 335 -1 O ILE A 332 N LYS A 290 SHEET 5 D 5 LEU A 320 CYS A 324 -1 N LEU A 321 O ILE A 333 SHEET 1 E 2 PHE A 378 ILE A 379 0 SHEET 2 E 2 SER A 404 ARG A 405 -1 O SER A 404 N ILE A 379 SHEET 1 F 2 CYS A 388 VAL A 390 0 SHEET 2 F 2 VAL A 396 VAL A 398 -1 O LYS A 397 N LEU A 389 SHEET 1 G 2 TYR A 412 THR A 413 0 SHEET 2 G 2 LYS A 434 PHE A 435 -1 O PHE A 435 N TYR A 412 LINK C ASN A 68 N SEP A 69 1555 1555 1.33 LINK C SEP A 69 N LYS A 70 1555 1555 1.33 CISPEP 1 PRO A 328 PRO A 329 0 -0.35 SITE 1 AC1 2 GLU A 481 ILE A 521 SITE 1 AC2 14 TYR A 272 VAL A 275 ALA A 288 LYS A 290 SITE 2 AC2 14 GLU A 305 MET A 309 THR A 334 GLU A 335 SITE 3 AC2 14 PHE A 336 MET A 337 GLY A 340 LEU A 389 SITE 4 AC2 14 ALA A 399 ASP A 400 SITE 1 AC3 5 TYR A 345 GLY A 391 GLU A 392 ASN A 393 SITE 2 AC3 5 HIS A 394 SITE 1 AC4 4 THR A 197 ALA A 198 THR A 296 MET A 297 CRYST1 79.688 117.266 60.416 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012549 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008528 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016552 0.00000